<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Anesthesia</title>
<link>https://repository.ju.edu.et//handle/123456789/170</link>
<description/>
<pubDate>Wed, 10 Jun 2026 08:36:52 GMT</pubDate>
<dc:date>2026-06-10T08:36:52Z</dc:date>
<item>
<title>Prevalence and determinants of postoperative nausea And vomiting among adult patients undergoing Elective surgery at jimma university comprehensive Specialized hospital, jimma, south west ethiopia</title>
<link>https://repository.ju.edu.et//handle/123456789/10282</link>
<description>Prevalence and determinants of postoperative nausea And vomiting among adult patients undergoing Elective surgery at jimma university comprehensive Specialized hospital, jimma, south west ethiopia
Dereje girma; Birhanu gemechu
Postoperative nausea and vomiting (PONV) is defined as the occurrence of&#13;
nausea and vomiting after a surgical procedure. It is a common complication following surgery&#13;
and can cause discomfort and distress to patients. The severity ranges from mild discomfort to&#13;
more severe and persistent episodes. PONV is a multifactorial phenomenon influenced by&#13;
patient-related, surgical, and anaesthesia-related factors. Identifying specific risk factors and&#13;
developing predictive models can aid in risk stratification and individualized management
</description>
<pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repository.ju.edu.et//handle/123456789/10282</guid>
<dc:date>2026-03-01T00:00:00Z</dc:date>
</item>
<item>
<title>Incidence and associated risk factors of awareness with recall under General anesthesia among non-cardiac and non-obstetric adult Patients in jimma university comprehensive specialized hospital, jimma, Ethiopia</title>
<link>https://repository.ju.edu.et//handle/123456789/10270</link>
<description>Incidence and associated risk factors of awareness with recall under General anesthesia among non-cardiac and non-obstetric adult Patients in jimma university comprehensive specialized hospital, jimma, Ethiopia
Yishak Feleke; Gemechis zerihun
</description>
<pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repository.ju.edu.et//handle/123456789/10270</guid>
<dc:date>2026-03-01T00:00:00Z</dc:date>
</item>
<item>
<title>Satisfaction with cleft care and perceived barriers to Care access among cleft care consumers at jimma University comprehensive specialized hospital, jimma, Ethiopia</title>
<link>https://repository.ju.edu.et//handle/123456789/10265</link>
<description>Satisfaction with cleft care and perceived barriers to Care access among cleft care consumers at jimma University comprehensive specialized hospital, jimma, Ethiopia
Matusala Tessema; Diriba
</description>
<pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repository.ju.edu.et//handle/123456789/10265</guid>
<dc:date>2026-03-01T00:00:00Z</dc:date>
</item>
<item>
<title>Magnitude, clinical presentations, outcomes and  Associated factors of guillain-barre syndrome among  Pediatrics admited jumc southwest, Ethiopia</title>
<link>https://repository.ju.edu.et//handle/123456789/9910</link>
<description>Magnitude, clinical presentations, outcomes and  Associated factors of guillain-barre syndrome among  Pediatrics admited jumc southwest, Ethiopia
Dereje Abunu; Gashaw Tadesse
Background: Guillain-Barre Syndrome (GBS) is a rare but serious neurological disorder in &#13;
children, often requiring intensive care. This study aimed to evaluate the prevalence, clinical &#13;
characteristics, management, outcome and its predictor of pediatric GBS cases admitted to &#13;
JUMC (a tertiary care center) over a five-year period. &#13;
Methods: An institution based cross-sectional study was conducted on 72 pediatric patients &#13;
(&lt;15years) admitted to JUMC for the diagnosis of GBS fulfilling the Brighton Criteria for GBS. &#13;
Clinical features, diagnostic procedures, treatments, outcomes and its predictors were reviewed. &#13;
Statistical associations between key clinical variables and outcomes were analyzed using logistic &#13;
regression. &#13;
Results: The prevalence of GBS was 0.9 per 100,000 children in the general pediatric &#13;
population and 0.5 per 100 pediatric hospital admissions, it’s found to be a peaked in children &#13;
aged 1–5 years. Males constituted 62.5% of the study, with a median age of 8.3 years. The &#13;
majority (84.5%) presented with ascending symmetrical weakness, with 85% reaching peak &#13;
weakness within two weeks. Quadriplegia was noted in 48.5% of patients, and neuropathic pain &#13;
was reported in 37%. Antecedent infections, particularly upper respiratory tract infections, were &#13;
identified in 80.6% of cases, with most cases occurring between September and December. &#13;
Cranial nerve involvement was observed in 38.9.3%, and autonomic dysfunction in 27.8%. &#13;
Intensive care was required for 58.9% of patients, with 37.3% needing mechanical ventilation. &#13;
Respiratory failure and requirement for mechanical ventilation significantly increased the odds &#13;
of mortality (AOR = 7.6, p = 0.007; AOR = 9.2, p = 0.027). Complications included ventilator&#13;
associated pneumonia (42%), aspiration pneumonia (27%), urinary tract infections (17%), and &#13;
bed sore (3%) &#13;
Lumbar punctures revealed albumin cytological dissociation in 66.7% of cases. Despite this, &#13;
only 9.6% of patients received intravenous immunoglobulin (IVIG), and 15% of these &#13;
experienced treatment-related worsening. At discharge, 45% of patients showed partial &#13;
recovery, 40.2% had no motor improvement without progression, and 5.6% died. The primary &#13;
causes of death were respiratory failure and autonomic dysfunction. &#13;
ii &#13;
Conclusion: Pediatric GBS presents significant morbidity and mortality, with respiratory failure &#13;
and requirement for mechanical ventilation being critical determinants of outcomes. Early &#13;
recognition of respiratory complications and timely intensive care interventions are essential to &#13;
improve outcomes and survival rate. Future studies should explore the role of &#13;
electrophysiological testing, long term outcome and optimal therapeutic strategies, including &#13;
broader use of IVIG.
</description>
<pubDate>Sat, 01 Mar 2025 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://repository.ju.edu.et//handle/123456789/9910</guid>
<dc:date>2025-03-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
